Announcement
Gravity Medical Technology announced the Supernova stent retriever and Neutron aspiration catheter in 2024 as parts of a stroke-intervention portfolio. The stent retriever is designed to engage and remove a clot from a blocked brain artery, while the catheter is designed for aspiration and navigation through blood vessels. The company's product overview describes both devices and links to their technical materials.
The launch emphasized access to mechanical thrombectomy in regions where specialist treatment is limited. That is an important goal, but a device announcement alone cannot establish comparative effectiveness, a clinical benefit for every patient, or authorization in every country. Gravity Medical's later site lists trials, case studies, and country-specific milestones that should be evaluated separately from what was known at the 2024 launch.
These devices are for trained interventional specialists, not consumer self-use. Hospitals and clinicians should consult current regulatory status, instructions for use, clinical evidence, procurement terms, and local protocols. A person experiencing possible stroke symptoms needs emergency medical assessment immediately; this historical product announcement is not treatment guidance.